Intuitive Surgical, Inc. (0R29.L)
USD 532.14
(2.67%)
USD 532.14
(2.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.76 Billion USD | 45.86% |
| 2022 | 1.21 Billion USD | -33.48% |
| 2021 | 1.82 Billion USD | 135.39% |
| 2020 | 773.6 Million USD | -43.72% |
| 2019 | 1.37 Billion USD | 14.6% |
| 2018 | 1.19 Billion USD | 13.73% |
| 2017 | 1.05 Billion USD | 11.57% |
| 2016 | 945.2 Million USD | 27.73% |
| 2015 | 740 Million USD | 35.83% |
| 2014 | 544.8 Million USD | -36.09% |
| 2013 | 852.5 Million USD | -2.92% |
| 2012 | 878.1 Million USD | 26.38% |
| 2011 | 694.8 Million USD | 25.14% |
| 2010 | 555.2 Million USD | 47.1% |
| 2009 | 377.43 Million USD | 21.43% |
| 2008 | 310.83 Million USD | 50.35% |
| 2007 | 206.74 Million USD | 92.58% |
| 2006 | 107.35 Million USD | 56.1% |
| 2005 | 68.77 Million USD | 224.64% |
| 2004 | 21.18 Million USD | 278.32% |
| 2003 | -11.88 Million USD | 41.24% |
| 2002 | -20.21 Million USD | 0.8% |
| 2001 | -20.38 Million USD | 8.5% |
| 2000 | -22.27 Million USD | -13.95% |
| 1999 | -19.54 Million USD | 36.47% |
| 1998 | -30.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 577.3 Million USD | 1.76% |
| 2024 Q1 | 469.4 Million USD | 4.26% |
| 2024 Q2 | 567.3 Million USD | 20.86% |
| 2023 Q3 | 465.8 Million USD | 27.3% |
| 2023 Q2 | 365.9 Million USD | 24.08% |
| 2023 Q1 | 294.9 Million USD | 10.74% |
| 2023 FY | 1.76 Billion USD | 45.86% |
| 2023 Q4 | 450.2 Million USD | -3.35% |
| 2022 Q3 | 309.1 Million USD | -0.8% |
| 2022 Q1 | 324.3 Million USD | -28.0% |
| 2022 FY | 1.21 Billion USD | -33.48% |
| 2022 Q4 | 266.3 Million USD | -13.85% |
| 2022 Q2 | 311.6 Million USD | -3.92% |
| 2021 FY | 1.82 Billion USD | 135.39% |
| 2021 Q2 | 511.2 Million USD | 22.65% |
| 2021 Q1 | 416.8 Million USD | 0.24% |
| 2021 Q4 | 450.4 Million USD | 1.76% |
| 2021 Q3 | 442.6 Million USD | -13.42% |
| 2020 Q3 | 270.4 Million USD | 235.48% |
| 2020 FY | 773.6 Million USD | -43.72% |
| 2020 Q1 | 283 Million USD | -28.82% |
| 2020 Q2 | 80.6 Million USD | -71.52% |
| 2020 Q4 | 415.8 Million USD | 53.77% |
| 2019 FY | 1.37 Billion USD | 14.6% |
| 2019 Q4 | 397.6 Million USD | 8.72% |
| 2019 Q3 | 365.7 Million USD | 1.87% |
| 2019 Q2 | 359 Million USD | 42.35% |
| 2019 Q1 | 252.2 Million USD | -24.04% |
| 2018 Q2 | 277.4 Million USD | 0.25% |
| 2018 Q4 | 332 Million USD | 5.97% |
| 2018 FY | 1.19 Billion USD | 13.73% |
| 2018 Q1 | 276.7 Million USD | -15.38% |
| 2018 Q3 | 313.3 Million USD | 12.94% |
| 2017 Q2 | 257.5 Million USD | 34.46% |
| 2017 Q1 | 191.5 Million USD | -27.57% |
| 2017 FY | 1.05 Billion USD | 11.57% |
| 2017 Q4 | 327 Million USD | 17.37% |
| 2017 Q3 | 278.6 Million USD | 8.19% |
| 2016 Q4 | 264.4 Million USD | 3.12% |
| 2016 Q2 | 245.4 Million USD | 37.09% |
| 2016 Q3 | 256.4 Million USD | 4.48% |
| 2016 FY | 945.2 Million USD | 27.73% |
| 2016 Q1 | 179 Million USD | -27.21% |
| 2015 Q1 | 130.4 Million USD | -29.93% |
| 2015 Q2 | 173.8 Million USD | 33.28% |
| 2015 Q3 | 189.9 Million USD | 9.26% |
| 2015 FY | 740 Million USD | 35.83% |
| 2015 Q4 | 245.9 Million USD | 29.49% |
| 2014 Q4 | 186.1 Million USD | 16.97% |
| 2014 Q1 | 56.6 Million USD | -72.87% |
| 2014 FY | 544.8 Million USD | -36.09% |
| 2014 Q2 | 143 Million USD | 152.65% |
| 2014 Q3 | 159.1 Million USD | 11.26% |
| 2013 Q4 | 208.6 Million USD | 19.75% |
| 2013 Q2 | 218.5 Million USD | -13.02% |
| 2013 Q1 | 251.2 Million USD | 1.25% |
| 2013 FY | 852.5 Million USD | -2.92% |
| 2013 Q3 | 174.2 Million USD | -20.27% |
| 2012 Q1 | 193.3 Million USD | -3.11% |
| 2012 FY | 878.1 Million USD | 26.38% |
| 2012 Q4 | 248.1 Million USD | 17.36% |
| 2012 Q3 | 211.4 Million USD | -6.17% |
| 2012 Q2 | 225.3 Million USD | 16.55% |
| 2011 Q4 | 199.5 Million USD | 11.51% |
| 2011 Q3 | 178.9 Million USD | 6.42% |
| 2011 FY | 694.8 Million USD | 25.14% |
| 2011 Q2 | 168.1 Million USD | 13.35% |
| 2011 Q1 | 148.3 Million USD | -3.51% |
| 2010 Q2 | 139.7 Million USD | 7.71% |
| 2010 Q4 | 153.7 Million USD | 16.35% |
| 2010 Q3 | 132.1 Million USD | -5.44% |
| 2010 Q1 | 129.7 Million USD | 1.03% |
| 2010 FY | 555.2 Million USD | 47.1% |
| 2009 Q1 | 45.02 Million USD | -45.58% |
| 2009 FY | 377.43 Million USD | 21.43% |
| 2009 Q4 | 128.38 Million USD | 22.86% |
| 2009 Q3 | 104.49 Million USD | 4.97% |
| 2009 Q2 | 99.54 Million USD | 121.07% |
| 2008 Q4 | 82.73 Million USD | -2.7% |
| 2008 FY | 310.83 Million USD | 50.35% |
| 2008 Q3 | 85.03 Million USD | 8.74% |
| 2008 Q2 | 78.19 Million USD | 20.54% |
| 2008 Q1 | 64.87 Million USD | -11.6% |
| 2007 Q3 | 53.98 Million USD | 19.89% |
| 2007 Q2 | 45.03 Million USD | 31.14% |
| 2007 Q1 | 34.33 Million USD | -3.12% |
| 2007 FY | 206.74 Million USD | 92.58% |
| 2007 Q4 | 73.38 Million USD | 35.92% |
| 2006 Q3 | 25.67 Million USD | 4.77% |
| 2006 FY | 107.35 Million USD | 56.1% |
| 2006 Q2 | 24.5 Million USD | 12.8% |
| 2006 Q1 | 21.72 Million USD | -7.59% |
| 2006 Q4 | 35.44 Million USD | 38.05% |
| 2005 Q2 | 15.33 Million USD | 72.07% |
| 2005 Q3 | 21 Million USD | 36.97% |
| 2005 Q4 | 23.51 Million USD | 11.91% |
| 2005 Q1 | 8.91 Million USD | -18.57% |
| 2005 FY | 68.77 Million USD | 224.64% |
| 2004 Q4 | 10.94 Million USD | 99.51% |
| 2004 Q1 | 283 Thousand USD | 105.04% |
| 2004 Q2 | 4.46 Million USD | 1478.45% |
| 2004 Q3 | 5.48 Million USD | 22.83% |
| 2004 FY | 21.18 Million USD | 278.32% |
| 2003 Q2 | 531 Thousand USD | 116.94% |
| 2003 FY | -11.88 Million USD | 41.24% |
| 2003 Q1 | -3.13 Million USD | -4.67% |
| 2003 Q4 | -5.61 Million USD | -53.24% |
| 2003 Q3 | -3.66 Million USD | -789.83% |
| 2002 Q3 | -6.84 Million USD | -60.35% |
| 2002 Q4 | -2.99 Million USD | 56.23% |
| 2002 Q2 | -4.26 Million USD | 30.22% |
| 2002 Q1 | -6.11 Million USD | -20.87% |
| 2002 FY | -20.21 Million USD | 0.8% |
| 2001 Q4 | -5.05 Million USD | 13.28% |
| 2001 Q2 | -4.94 Million USD | -8.59% |
| 2001 Q1 | -4.55 Million USD | 27.98% |
| 2001 FY | -20.38 Million USD | 8.5% |
| 2001 Q3 | -5.83 Million USD | -18.07% |
| 2000 Q4 | -6.31 Million USD | -16.65% |
| 2000 Q3 | -5.41 Million USD | -4.68% |
| 2000 FY | -22.27 Million USD | -13.95% |
| 2000 Q2 | -5.17 Million USD | 3.61% |
| 2000 Q1 | -5.36 Million USD | 0.0% |
| 1999 FY | -19.54 Million USD | 36.47% |
| 1998 FY | -30.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 1440.791% |
| Accuray Incorporated | 504 Thousand USD | -350455.556% |
| Align Technology, Inc. | 643.33 Million USD | -174.63% |
| Elevance Health Inc. | 133.96 Billion USD | 98.681% |
| AxoGen, Inc. | -21.46 Million USD | 8332.224% |
| Boston Scientific Corporation | 2.34 Billion USD | 24.592% |
| CVS Health Corporation | 13.74 Billion USD | 87.144% |
| Cardinal Health, Inc. | 1.24 Billion USD | -42.14% |
| Centene Corporation | 2.93 Billion USD | 39.7% |
| DaVita Inc. | 1.6 Billion USD | -10.233% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 81.647% |
| Hologic, Inc. | 970.2 Million USD | -82.107% |
| Humana Inc. | 4.01 Billion USD | 55.973% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -61.039% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -143.495% |
| Masimo Corporation | 136.5 Million USD | -1194.359% |
| McKesson Corporation | 3.9 Billion USD | 54.802% |
| Patterson Companies, Inc. | 252.92 Million USD | -598.55% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -40.0% |
| ResMed Inc. | 1.31 Billion USD | -33.859% |
| Henry Schein, Inc. | 615 Million USD | -187.285% |
| Teladoc Health, Inc. | -248.55 Million USD | 810.834% |
| Universal Health Services, Inc. | 1.17 Billion USD | -50.317% |
| Veeva Systems Inc. | 429.33 Million USD | -311.521% |
| Baxter International Inc. | 390 Million USD | -353.026% |
| Becton, Dickinson and Company | 2.11 Billion USD | 16.305% |
| Danaher Corporation | 5.38 Billion USD | 67.166% |
| Stryker Corporation | 3.88 Billion USD | 54.558% |
| Medtronic plc | 5.14 Billion USD | 65.653% |